Navigation Links
China Medical Technologies and Leica Microsystems Announce Collaboration
Date:8/8/2011

using molecular diagnostic technologies including Fluorescent in situ Hybridization (FISH) and Surface Plasmon Resonance (SPR) and an immunodiagnostic technology, Enhanced Chemiluminescence Immunoassay (ECLIA), to develop, manufacture and distribute diagnostic products used for the detection of various cancers, diseases and disorders as well as companion diagnostic tests for targeted cancer drugs. The Company generates all of its revenues in China through the sale of diagnostic consumables including FISH probes, SPR-based DNA chips and ECLIA reagent kits to hospitals which are recurring users of the consumables for their patients. The Company sells FISH probes and SPR chips to large hospitals through its direct sales force and ECLIA reagent kits to small and mid-size hospitals through distributors. For more information, please visit http://www.chinameditech.com.

Safe Harbor StatementThis press release contains forward-looking statements. These statements constitute "forward-looking" statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Among other things, the quotations from management in this press release contain forward-looking statements. Such statements involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Further information regarding these and other risks is included in CMED's filings with the U.S. Securities and Exchange Commission, including its annual report on Form 20-F. CMED does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required
'/>"/>

SOURCE China Medical Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. China Sky One Medical Announces Conference Call to Discuss Second Quarter 2011 Results
2. China Nepstar Chain Drugstore to Report Second Quarter 2011 Financial Results on August 23
3. China Medical Technologies to Announce Results for the First Fiscal Quarter Ended June 30, 2011 on August 16, 2011
4. China Pharma Holdings, Inc. to Report Second Quarter 2011 Financial Results on August 11, 2011
5. China Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others
6. China Kanghui Holdings to Report Second Quarter 2011 Financial Results on August 16, 2011
7. China Nuvo Solar Target Acquisition SurgLine Announces Third-Party Distribution Agreement With OptiMedical, Corp.
8. Boston Scientific Announces Five-Year, $150 Million Investment in China to Accelerate Commercial Expansion
9. PolyGel Signs Long Term Exclusive Agreement With Chinas Largest Distributor of Healthcare Products
10. China Cardiac Catheters and Guidewires - Market Trends Till 2016
11. Aeras and China National Biotech Group Sign Memorandum of Understanding for TB Vaccine R&D Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... AUGUSTA, Ga. , March 27, 2015  Holographic ... innovator in the field of holographic medical imaging, is ... of its Kickstarter campaign. Launching on April 20 th ... Voxbox and Voxbox Pro. The 8-inch and 22-inch displays ... at home for the first time. In addition to ...
(Date:3/27/2015)... , March 27, 2015   Cypher Genomics, ... announced new data showing that, compared to a ... technology provided highly equivalent interpretations of whether certain ... did so in a fraction of the time. ... for more comprehensive genetic analysis in non-invasive prenatal ...
(Date:3/27/2015)... , March 27, 2015 XRpro Sciences, ... drug discovery and development services which features high ... pharmaceutical industry, announced financial results for the year ... C.  Tyson, Chairman of XRpro Sciences commented, "We ... transition from development stage to commercial stage in ...
Breaking Medicine Technology:Holographic Optical Technologies brings cutting-edge holograms to consumer market through upcoming Kickstarter campaign 2Holographic Optical Technologies brings cutting-edge holograms to consumer market through upcoming Kickstarter campaign 3New Data at ACMG Shows Cypher's Software Can Automate Interpretation of Genetic Variants to Advance Non-invasive Prenatal Testing 2New Data at ACMG Shows Cypher's Software Can Automate Interpretation of Genetic Variants to Advance Non-invasive Prenatal Testing 3XRpro Sciences Announces Fiscal 2014 Financial Results 2XRpro Sciences Announces Fiscal 2014 Financial Results 3XRpro Sciences Announces Fiscal 2014 Financial Results 4
... AUSTIN, Texas, April 27, 2011 Hanger Orthopedic Group, Inc. ... million for the quarter ended March 31, 2011, an increase ... first quarter of 2010.  Adjusted diluted earnings per share, which ... $0.19 for the first quarter of 2011, an 18.8% increase ...
... N.Y. and BERLIN, April 27, 2011 Regeneron ... today announced positive top-line results for VEGF Trap-Eye (aflibercept ophthalmic ... macular edema due to central retinal vein occlusion (CRVO).  The ... the similarly designed Phase 3 COPERNICUS study that were announced ...
Cached Medicine Technology:Hanger Orthopedic Group Reports First Quarter Results 2Hanger Orthopedic Group Reports First Quarter Results 3Hanger Orthopedic Group Reports First Quarter Results 4Hanger Orthopedic Group Reports First Quarter Results 5Hanger Orthopedic Group Reports First Quarter Results 6Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Second Phase 3 Study in Central Retinal Vein Occlusion 2Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Second Phase 3 Study in Central Retinal Vein Occlusion 3Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Second Phase 3 Study in Central Retinal Vein Occlusion 4Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Second Phase 3 Study in Central Retinal Vein Occlusion 5Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Second Phase 3 Study in Central Retinal Vein Occlusion 6Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Second Phase 3 Study in Central Retinal Vein Occlusion 7
(Date:3/29/2015)... Chicago, IL (PRWEB) March 29, 2015 ... Foundation for Women’s Cancer announce today that ... 2015 recipient of the Claudia Cohen Research Foundation Prize ... presented at the Society of Gynecologic Oncology 46th Annual ... is Director of the Cedars-Sinai Women’s Cancer Program at ...
(Date:3/29/2015)... 29, 2015 The federal court ... ) pending in the U.S. District Court, Northern ... Case Management Conference for April 21st at 1:30 ... address the progress of product liability claims filed ... attacks, strokes and other cardiovascular complications due to ...
(Date:3/29/2015)... March 29, 2015 Youth Villages will ... in Oregon to assess the feasibility of implementing a ... and behavioral problems and their families. , Third Sector ... participants that will be provided technical assistance throughout 2015 ... join six other national awardees chosen by Third Sector. ...
(Date:3/29/2015)... North American Seminars receives Texas Board Physical Therapy ... . , Utilizing Pilates to Enhance Rehab ... # 56399TX      , The Interactive Shoulder Algorithm ... 10.5 hours - Texas Board of Physical Therapy      ... the SI Joint - 10 hours - Texas Board ...
(Date:3/28/2015)... Rocket Pure , a manufacturer of natural ... their new natural sunscreen. They are offering the sunscreen ... options come with a bonus lip balm sunscreen. , The ... Click to see the natural sunscreen on Amazon ... is made with non-nano zinc oxide and provides broad-based protection ...
Breaking Medicine News(10 mins):Health News:Dr. Beth Y. Karlan Named Recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher 2015 2Health News:Dr. Beth Y. Karlan Named Recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher 2015 3Health News:Dr. Beth Y. Karlan Named Recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher 2015 4Health News:Federal Court Overseeing Testosterone Treatment Lawsuits Schedules April Case Management Conference 2Health News:Federal Court Overseeing Testosterone Treatment Lawsuits Schedules April Case Management Conference 3Health News:Youth Villages Partners with Two Oregon Counties to Advance Pay-for-Success Model to Help At-Risk Youth 2Health News:Youth Villages Partners with Two Oregon Counties to Advance Pay-for-Success Model to Help At-Risk Youth 3Health News:Youth Villages Partners with Two Oregon Counties to Advance Pay-for-Success Model to Help At-Risk Youth 4Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 2Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 3
... Maintains its Top Spot, and Big Pharma Dominates Top ... Thomson,Scientific, part of The Thomson Corporation (NYSE: TOC ... the worldwide research and,business communities, today announced the availability ... Splash?" In this quarterly review of the scientific ...
... populations are an increasing issue for the Western world. The ... has been a rise in older men and women living ... relatives. A new study, funded by the Economic and Social ... a spouse or with others on the health and happiness ...
... favourable clinical outcome in women with ovarian carcinoma, and ... published this week in the online open access journal, ... of peptide hormones, and the receptor GPR54 have previously ... In this study, researchers have shown that kisspeptin and ...
... announced strong sales and earnings for its first,quarter ended September ... per diluted share, on revenues of $2,751,000. This compares to ... revenues of $2,424,000,for the first quarter of last year. ... 13.5% revenue growth, year over year -- Gross margin ...
... N.J., Nov. 14 Roche announced today,that ... has approved MIRCERA,(methoxy polyethylene glycol-epoetin beta) for ... failure (CRF) in adults, including patients,on dialysis ... commonly known as chronic,kidney disease (CKD). MIRCERA ...
... 14 The vast,majority of people required to ... law have failed to do so, according,to an ... Consumer Rights,(FTCR)., A California proposal modeled on ... correct for the affordability crisis faced by,Massachusetts residents. ...
Cached Medicine News:Health News:Thomson Scientific Publishes 'Who Is Making The Biggest Splash?' - a Quarterly Review of Scientific Literature on Drugs and Therapies From July - September 2007 2Health News:Thomson Scientific Publishes 'Who Is Making The Biggest Splash?' - a Quarterly Review of Scientific Literature on Drugs and Therapies From July - September 2007 3Health News:Living arrangements, health and well-being: A European perspective 2Health News:Predicting the future in ovarian cancer 2Health News:Biotel Announces Strong Results for the First Quarter Ended September 30, 2007, FDA 510(k) Clearance for the Braemar ER900 Wireless Event Recorder 2Health News:FDA Approves MIRCERA(R): First Renal Anemia Treatment with Monthly Maintenance Dosing 2Health News:FDA Approves MIRCERA(R): First Renal Anemia Treatment with Monthly Maintenance Dosing 3Health News:Consumer Group to Nunez: Massachusetts Mandatory Health Insurance Purchase Law Is No Model for California 2Health News:Consumer Group to Nunez: Massachusetts Mandatory Health Insurance Purchase Law Is No Model for California 3Health News:Consumer Group to Nunez: Massachusetts Mandatory Health Insurance Purchase Law Is No Model for California 4
... When someone suffers an episode of ... right away. The QuikDraw PRO quickly restores ... immediate pain relief.,With just a few sizes ... clothing sizes, the QuikDraw PRO will reduce ...
Shoulder Immobilizer with Body Strap Navy blue cotton. Thumb look helps keep hand in neutral position. Padded, 2" blue pile material laminated to foam shoulder and body strap. Fits left or right. 5/p...
... Shoulder Immobilizer with Contoured ... Navy cotton sling with foam-padded ... body straps. Quick-release closure buckles. ... 35 covered abduction wedge to ...
... Combining the therapeutic benefits of controlled ... hemarthrosis, swelling, and pain. The anatomically designed ... treatment.,The Shoulder Cryo/Cuff can be ordered with ... to larger chest circumferences.,All Cryo/Cuffs can be ...
Medicine Products: